NIC
VTVT icon

Northwest Investment Counselors’s vTv Therapeutics VTVT Stock Holding History

Northwest Investment Counselors’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13
Closed – – 551
2022
Q3 		$0 Buy
+13
New +$512 ﹤0.01% 572

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
V
Veritable Wilmington, Delaware $6.46B AUM 17.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.27B AUM 19.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northwest Investment Counselors's VTVT Position: Q4 2022 in Review

Northwest Investment Counselors sold out of vTv Therapeutics (VTVT) in Q4 2022, closing a stake of 13 shares.

Northwest Investment Counselors first reported a position in VTVT in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 30 funds tracked by Wall St. Rank hold VTVT as of Q4 2022.

  • Northwest Investment Counselors reported no remaining vTv Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Northwest Investment Counselors sold 13 vTv Therapeutics shares in Q4 2022.
  • Northwest Investment Counselors first reported a position in vTv Therapeutics in Q3 2022 and held it in 1 quarter.
  • Northwest Investment Counselors's vTv Therapeutics position peaked at $0 in Q3 2022.
  • 30 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2022.

Based on Northwest Investment Counselors's 13F filing for Q4 2022, filed 18 Jan 2023.